Canopy Partners, LLC Astrazeneca PLC Transaction History
Canopy Partners, LLC
- $205 Billion
- Q1 2024
A detailed history of Canopy Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Canopy Partners, LLC holds 4,763 shares of AZN stock, worth $365,798. This represents 0.16% of its overall portfolio holdings.
Number of Shares
4,763
Previous 3,804
25.21%
Holding current value
$365,798
Previous $256 Million
25.95%
% of portfolio
0.16%
Previous 0.16%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,248Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.71 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.77 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.3 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.65 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.33 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $238B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...